iBio, Inc. (IBIO)
1.69
-0.02
(-1.17%)
USD |
NASDAQ |
May 11, 10:38
iBio Market Cap : 58.38M for May 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.786B |
| Alnylam Pharmaceuticals, Inc. | 39.29B |
| Amgen, Inc. | 179.61B |
| Savara, Inc. | 1.091B |
| Biogen, Inc. | 29.43B |
Market Cap Related Metrics
| PS Ratio | 251.25 |
| Price to Book Value | 1.032 |
| Price | 1.69 |
| Earnings Yield | -59.53% |